As of June 2024 Maravai LifeSciences has a market cap of $1.81 Billion. This makes Maravai LifeSciences the world's 4246th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $1.81 B | 10.51% |
2023 | $1.64 B | -54.93% |
2022 | $3.65 B | -33.7% |
2021 | $5.50 B | 103.18% |
2020 | $2.71 B |
On Jun 16th, 2024 the market cap of Maravai LifeSciences was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Organovo ONVO | $13.09 M | -99.28% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | $0.38 B | -79.10% | ๐ฌ๐ง UK |
![]() Novavax NVAX | $2.06 B | 13.78% | ๐บ๐ธ USA |
![]() Novocure
NVCR | $2.08 B | 14.78% | Jersey |